Advisory Research’s Allergan plc AGN Stock Holding History

Advisory Research’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,308	Closed	-$1.28M	–	341
2015 Q1	$1.28M	Buy	+4,308	New	+$1.23M	0.01%	219
2014 Q2	–	Sell	-312	Closed	-$64K	–	715
2014 Q1	$64K	Buy	+312	New	+$61.8K	﹤0.01%	738

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Advisory Research's AGN Position: Q2 2015 in Review

Advisory Research sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 4,308 shares — an estimated $1.28M sold.

Advisory Research first reported a position in AGN in Q1 2014 and held it in 2 quarters. The position peaked at $1.28M in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

Advisory Research reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
Advisory Research sold 4,308 Allergan plc shares in Q2 2015, an estimated $1.28M.
Advisory Research first reported a position in Allergan plc in Q1 2014 and held it in 2 quarters.
Advisory Research's Allergan plc position peaked at $1.28M in Q1 2015.
1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Advisory Research's 13F filing for Q2 2015, filed 14 Aug 2015.